3 European Penny Stocks With Market Caps Under €300M To Consider

Dec 18, 2025
3-european-penny-stocks-with-market-caps-under-e300m-to-consider

Simply Wall St

4 min read

The European stock market has shown mixed performance recently, with indices such as Germany’s DAX gaining slightly while others like France’s CAC 40 have seen declines. Despite these fluctuations, the concept of penny stocks remains relevant for investors seeking opportunities in smaller or newer companies. While the term may seem outdated, it highlights a segment of the market where strong financials can lead to significant potential returns.

Name

Share Price

Market Cap

Financial Health Rating

Ariston Holding (BIT:ARIS)

€4.45

€1.54B

★★★★★☆

Orthex Oyj (HLSE:ORTHEX)

€4.72

€83.82M

★★★★★★

Lucisano Media Group (BIT:LMG)

€1.00

€14.86M

★★★★★☆

Angler Gaming (NGM:ANGL)

SEK3.60

SEK269.95M

★★★★★★

Angler Gaming (DB:0QM)

€0.37

€223.46M

★★★★★★

Libertas 7 (BME:LIB)

€3.14

€66.6M

★★★★★☆

Hultstrom Group (OM:HULT B)

SEK3.12

SEK189.82M

★★★★★☆

ForFarmers (ENXTAM:FFARM)

€4.295

€379.61M

★★★★★★

Deceuninck (ENXTBR:DECB)

€2.265

€313.07M

★★★★★★

Netgem (ENXTPA:ALNTG)

€0.772

€25.85M

★★★★★★

Click here to see the full list of 291 stocks from our European Penny Stocks screener.

Let’s uncover some gems from our specialized screener.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Oriola Oyj is involved in the wholesale of pharmaceuticals and health products across Sweden, Finland, and internationally, with a market cap of €202.29 million.

Operations: The company’s revenue is primarily derived from its Distribution segment, which accounts for €1.49 billion, followed by the Wholesale segment at €354 million.

Market Cap: €202.29M

Oriola Oyj, with a market cap of €202.29 million, is navigating through strategic changes to bolster its logistics capabilities by planning a new distribution centre in Järvenpää, Finland. Despite being unprofitable and facing challenges with short-term liabilities exceeding assets, the company has managed to decrease its debt-to-equity ratio significantly over five years. Oriola’s earnings are forecasted to grow substantially at 91.6% annually, although it currently trades well below estimated fair value and offers a dividend not covered by earnings. Recent management changes aim to enhance operational efficiency and support long-term growth strategies.

HLSE:ORIOLA Financial Position Analysis as at Dec 2025

HLSE:ORIOLA Financial Position Analysis as at Dec 2025

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: BrainCool AB (publ) is a medical device company that develops, markets, and sells medical cooling systems for the healthcare sector in Sweden with a market cap of SEK141.90 million.


Leave a comment